Role and Value of Inflammatory Markers in Brain Tumors : A Case Controlled Study

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

September 1, 2020

Study Completion Date

October 1, 2020

Conditions
Brain Tumor
Interventions
DIAGNOSTIC_TEST

Procalcitonin

Samples were categorized based on demographic data (age and gender), then the samples were categorized based on the type of brain tumor suffered. Once categorized, the levels of inflammatory markers was examined. Specimens were taken from the patient's peripheral blood examination and analyzed in laboratorium. The results of these examinations are grouped on a nominal scale, and analyzed statistically

Trial Locations (1)

20155

Faculty of Medicine Universitas Sumatera Utara, Medan

All Listed Sponsors
lead

Universitas Sumatera Utara

OTHER

NCT04634188 - Role and Value of Inflammatory Markers in Brain Tumors : A Case Controlled Study | Biotech Hunter | Biotech Hunter